Hsbc Holdings PLC decreased its holdings in Avantor, Inc. (NYSE:AVTR – Free Report) by 85.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 31,037 shares of the company’s stock after selling 187,250 shares during the quarter. Hsbc Holdings PLC’s holdings in Avantor were worth $243,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC lifted its stake in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC acquired a new position in shares of Avantor during the 2nd quarter valued at about $32,000. Private Trust Co. NA grew its holdings in Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares during the last quarter. Osaic Holdings Inc. raised its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after acquiring an additional 1,064 shares during the period. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Avantor during the 4th quarter worth about $32,000. Institutional investors and hedge funds own 95.08% of the company’s stock.
Avantor Stock Performance
Avantor stock opened at $13.69 on Tuesday. The stock has a 50-day simple moving average of $10.37 and a 200 day simple moving average of $9.44. The stock has a market capitalization of $9.26 billion, a price-to-earnings ratio of -16.29, a P/E/G ratio of 10.38 and a beta of 0.89. Avantor, Inc. has a 12-month low of $7.26 and a 12-month high of $15.93. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.
Analyst Ratings Changes
AVTR has been the topic of a number of research reports. Jefferies Financial Group raised shares of Avantor from an “underperform” rating to a “hold” rating and set a $13.00 target price on the stock in a research report on Wednesday, July 29th. Royal Bank Of Canada increased their price target on shares of Avantor from $9.00 to $14.00 and gave the company a “sector perform” rating in a report on Thursday. Citigroup boosted their price objective on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Sanford C. Bernstein started coverage on shares of Avantor in a research report on Friday, June 26th. They set a “market perform” rating and a $10.50 price objective for the company. Finally, Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Two equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $12.00.
Get Our Latest Stock Report on AVTR
Insiders Place Their Bets
In other Avantor news, Director Gregory T. Lucier bought 10,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were bought at an average cost of $8.32 per share, for a total transaction of $83,200.00. Following the transaction, the director owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.28% of the company’s stock.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Articles
- Five stocks we like better than Avantor
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
